sb 203580 has been researched along with xenon in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (xenon) | Trials (xenon) | Recent Studies (post-2010) (xenon) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 4,696 | 199 | 661 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Müllenheim, J; Obal, D; Preckel, B; Schlack, W; Toma, O; Weber, NC; Wolter, JI | 1 |
1 other study(ies) available for sb 203580 and xenon
Article | Year |
---|---|
The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK.
Topics: Anesthetics, Inhalation; Animals; Blotting, Western; Enzyme Activation; Enzyme Inhibitors; Fluorescent Antibody Technique, Direct; Heart; Imidazoles; Immunohistochemistry; Ischemic Preconditioning, Myocardial; Isoflurane; Male; Microscopy, Confocal; Myocardial Reperfusion; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Protein Kinase C; Protein Kinase C-epsilon; Pyridines; Rats; Rats, Wistar; Xenon | 2005 |